- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02996747
Low Grade Chondrosarcoma Versus Enchondroma (CONDRO1)
December 21, 2016 updated by: Costantino Errani, Istituto Ortopedico Rizzoli
Low Grade Chondrosarcoma Versus Enchondroma: Challenges in Diagnosis and Management
The purpose of this project is to verify possible clinical and radiological findings with regard to distinguishing enchondroma from low grade chondrosarcoma of the long bones.
In addition, this study presents the outcome of patients with enchondroma and low grade chondrosarcoma of the long bones who were treated with curettage (intralesional surgery).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators retrospectively review the records of 65 patients with enchondroma and 37 patients with low grade chondrosarcoma of the limbs treated by curettage between 1988 and 2014 in a single Institution.
Study Type
Observational
Enrollment (Actual)
102
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with chondroma or low grade chondrosarcoma of bone treated in a single Institution
Description
Inclusion Criteria:
- chondroma or low grade chondrosarcoma of long bones
Exclusion Criteria:
- chondroma or low grade chondrosarcoma of spine and pelvis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Local recurrence rate of patients with chondroma or low grade chondrosarcoma treated by curettage (intralesional surgery)
Time Frame: 36 months
|
36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
December 15, 2016
First Submitted That Met QC Criteria
December 16, 2016
First Posted (Estimate)
December 19, 2016
Study Record Updates
Last Update Posted (Estimate)
December 22, 2016
Last Update Submitted That Met QC Criteria
December 21, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0016890
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
publish a paper in international medical journal
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chondrosarcoma
-
National Cancer Institute (NCI)Active, not recruitingMesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Clear Cell Chondrosarcoma | Locally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Primary Central ChondrosarcomaFrance
-
Leiden University Medical CenterCompletedMyxoid Liposarcoma | Mesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Conventional ChondrosarcomaSpain, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingDedifferentiated Chondrosarcoma | Central Chondrosarcoma, Grade 2 | Central Chondrosarcoma, Grade 3 | Metastatic Clear Cell Sarcoma of Soft Tissue | Metastatic Primary Central Chondrosarcoma | Unresectable Primary Central ChondrosarcomaUnited States, Canada
-
National Cancer Institute (NCI)SuspendedMetastatic Primary Central Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Locally Advanced Unresectable Primary Central ChondrosarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
Italian Sarcoma GroupPharmaMarRecruitingMesenchymal ChondrosarcomaItaly
-
Istituto Ortopedico RizzoliCompleted
-
George Clinical Pty LtdGlaxoSmithKlineCompletedChondrosarcoma | Metastatic ChondrosarcomaUnited States, United Kingdom
-
Washington University School of MedicineWithdrawn
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)Active, not recruitingChordoma of Sacrum | Chordoma of Spine | Chordoma of Base of Skull | Chondrosarcoma of the Spine | Chondrosarcoma of the SacrumUnited States
Clinical Trials on curettage (intralesional surgery)
-
Matino, James, M.D.LifeCellUnknownPilonidal SinusUnited States
-
Bispebjerg HospitalCompletedKeratosis, ActinicDenmark
-
Zeynep Kamil Maternity and Pediatric Research and...UnknownEndometrial DiseaseTurkey
-
Chengde Central HospitalCompletedCaesarean Scar Pregnancy | Ultrasound Scoring SystemChina
-
Istanbul UniversityWithdrawn
-
Saint Thomas Hospital, PanamaCompletedEclampsia | Pre-EclampsiaPanama
-
Chaitanya Hospital, PuneUnknownMuscular Dystrophy | Duchenne Muscular DystrophyIndia
-
Amsterdam UMC, location VUmcCompletedCicatrix | Keloid | HypertrophicNetherlands
-
Milton S. Hershey Medical CenterCompletedSeborrheic KeratosisUnited States
-
Odense University HospitalCompleted